Limits...
Levels of spending and resource allocation to HIV programs and services in Latin America and the Caribbean.

Arán-Matero D, Amico P, Arán-Fernandez C, Gobet B, Izazola-Licea JA, Avila-Figueroa C - PLoS ONE (2011)

Bottom Line: International funds represented 5.4 percent of total HIV funding in the region, but they supplied the majority of the effort to reach most-at-risk-populations (MARPs).However, prevalence rates among men who have sex with men (MSM) still reached over 25 percent in some countries.These threats call for strengthened actions by civil society and governments to protect and advance gains against HIV in LAC.

View Article: PubMed Central - PubMed

Affiliation: Promotion of Economic Development (PROMODE), Joao Pessoa, Brazil.

ABSTRACT

Background: An estimated 1.86 million people are living with HIV in Latin America and the Caribbean (LAC). The region is comprised of mainly middle-income countries with steady economic growth while simultaneously there are enormous social inequalities and several concentrated AIDS epidemics. This paper describes HIV spending patterns in LAC countries including analysis of the levels and patterns of domestic HIV spending from both public and international sources.

Methods and findings: We conducted an extensive analysis of the most recently available data from LAC countries using the National AIDS Spending Assessment tool. The LAC countries spent a total of US$ 1.59 billion on HIV programs and services during the latest reported year. Countries providing detailed information on spending showed that high percentages are allocated to treatment and care (75.1%) and prevention (15.0%). Domestic sources accounted for 93.6 percent of overall spending and 79 percent of domestic funds were directed to treatment and care. International funds represented 5.4 percent of total HIV funding in the region, but they supplied the majority of the effort to reach most-at-risk-populations (MARPs). However, prevalence rates among men who have sex with men (MSM) still reached over 25 percent in some countries.

Conclusions: Although countries in the region have increasingly sustained their response from domestic sources, still there are future challenges: 1) The growing number of new HIV infections and more people-living-with-HIV (PLWH) eligible to receive antiretroviral treatment (ART); 2) Increasing ART coverage along with high prices of antiretroviral drugs; and 3) The funding for prevention activities among MARPs rely almost exclusively on external donors. These threats call for strengthened actions by civil society and governments to protect and advance gains against HIV in LAC.

Show MeSH

Related in: MedlinePlus

Treatment and Care Spending Per Person on ART in 9 LAC Countries in 2008.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC3142155&req=5

pone-0022373-g002: Treatment and Care Spending Per Person on ART in 9 LAC Countries in 2008.

Mentions: Figure 2 shows 9 countries' total spending on care and treatment divided by the number of people on ART in the country. On average, ART was responsible for half of the care and treatment budget. Therefore, these do not represent the unit costs of ART, but rather the cost per person on treatment and care including drug and non-drugs costs. There is wide variation in the average cost of treatment ranging from US$ 843 in Peru to US$ 3,128 in Mexico.


Levels of spending and resource allocation to HIV programs and services in Latin America and the Caribbean.

Arán-Matero D, Amico P, Arán-Fernandez C, Gobet B, Izazola-Licea JA, Avila-Figueroa C - PLoS ONE (2011)

Treatment and Care Spending Per Person on ART in 9 LAC Countries in 2008.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC3142155&req=5

pone-0022373-g002: Treatment and Care Spending Per Person on ART in 9 LAC Countries in 2008.
Mentions: Figure 2 shows 9 countries' total spending on care and treatment divided by the number of people on ART in the country. On average, ART was responsible for half of the care and treatment budget. Therefore, these do not represent the unit costs of ART, but rather the cost per person on treatment and care including drug and non-drugs costs. There is wide variation in the average cost of treatment ranging from US$ 843 in Peru to US$ 3,128 in Mexico.

Bottom Line: International funds represented 5.4 percent of total HIV funding in the region, but they supplied the majority of the effort to reach most-at-risk-populations (MARPs).However, prevalence rates among men who have sex with men (MSM) still reached over 25 percent in some countries.These threats call for strengthened actions by civil society and governments to protect and advance gains against HIV in LAC.

View Article: PubMed Central - PubMed

Affiliation: Promotion of Economic Development (PROMODE), Joao Pessoa, Brazil.

ABSTRACT

Background: An estimated 1.86 million people are living with HIV in Latin America and the Caribbean (LAC). The region is comprised of mainly middle-income countries with steady economic growth while simultaneously there are enormous social inequalities and several concentrated AIDS epidemics. This paper describes HIV spending patterns in LAC countries including analysis of the levels and patterns of domestic HIV spending from both public and international sources.

Methods and findings: We conducted an extensive analysis of the most recently available data from LAC countries using the National AIDS Spending Assessment tool. The LAC countries spent a total of US$ 1.59 billion on HIV programs and services during the latest reported year. Countries providing detailed information on spending showed that high percentages are allocated to treatment and care (75.1%) and prevention (15.0%). Domestic sources accounted for 93.6 percent of overall spending and 79 percent of domestic funds were directed to treatment and care. International funds represented 5.4 percent of total HIV funding in the region, but they supplied the majority of the effort to reach most-at-risk-populations (MARPs). However, prevalence rates among men who have sex with men (MSM) still reached over 25 percent in some countries.

Conclusions: Although countries in the region have increasingly sustained their response from domestic sources, still there are future challenges: 1) The growing number of new HIV infections and more people-living-with-HIV (PLWH) eligible to receive antiretroviral treatment (ART); 2) Increasing ART coverage along with high prices of antiretroviral drugs; and 3) The funding for prevention activities among MARPs rely almost exclusively on external donors. These threats call for strengthened actions by civil society and governments to protect and advance gains against HIV in LAC.

Show MeSH
Related in: MedlinePlus